Evoke is the only FDA-approved therapy with 24-month follow-up from a clinical study, according to a news release. A full commercial release is scheduled for 2023.
Evoke uses closed-loop technology and is designedto treat trunk and/or limb pain. The device earned FDA approval in March.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
